文献速递皮肤肿瘤

StARDISC研究:角质形成细胞皮肤癌的转诊延迟、生长、侵袭性与切除充分性

St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.
PubMed 文献 · Br J Dermatol · 2025-01-01

英国一项回顾性队列研究纳入728例患者共872次切除(基底细胞癌454例,鳞状细胞癌418例),发现病变持续时间越长,基底细胞癌和鳞状细胞癌的表面面积和厚度越大;鳞状细胞癌在3个月后厚度显著增加,且高危组织学参数增多;高危参数越多,切除充分性越差。

要点

  • 病变持续时间延长与角质形成细胞皮肤癌面积和厚度增加相关
  • 鳞状细胞癌在3个月后厚度显著增加,应优先早期切除
  • 高危组织学参数越多,基底细胞癌和鳞状细胞癌的切除充分性越差

核心结论

  • 病变持续时间延长导致角质形成细胞皮肤癌厚度和面积增加,高危因素增多,对手术切除边缘产生负面影响。
  • 鳞状细胞癌在3个月时厚度显著增加,而基底细胞癌无此关联,支持优先早期切除鳞状细胞癌。

研究设计与样本

  • 回顾性队列研究,随机抽取2019年1月至6月转诊至某整形外科皮肤癌中心的基底细胞癌和鳞状细胞癌患者。
  • 共纳入728例患者(男397例,女331例;中位年龄77岁,四分位距72-85),共872次切除(基底细胞癌454次,鳞状细胞癌418次)。

主要发现

  • 多变量回归显示,病变持续时间越长,基底细胞癌表面面积和厚度增加(P<0.001和P=0.001),鳞状细胞癌表面面积和厚度增加(均P<0.001)。
  • 鳞状细胞癌病变时间越长,出现直径>40 mm(P<0.001)、厚度>6 mm(P<0.001)及极高危因素总数(P<0.001)的可能性增加。
  • 病变持续时间>3个月的鳞状细胞癌中位表面面积大于≤3个月者(706.9 mm² vs. 295.3 mm²,P<0.001),中位厚度也更大(3.5 mm vs. 3 mm,P<0.001)。
  • 病变持续时间>3个月的基底细胞癌中位表面面积大于≤3个月者(263.9 mm² vs. 131.9 mm²,P<0.001)。
  • 随着高危或极高危参数数量增加,基底细胞癌和鳞状细胞癌的充分切除率总体下降。

关键数值与推荐

  • 英国皮肤科医师协会(BAD)指南定义了基底细胞癌和鳞状细胞癌的高危和极高危组织学参数,本研究据此评估风险。
  • 手术切除时,深度至少应达1毫米,并切除周围边缘。
  • 头颈部鳞状细胞癌和基底细胞癌最易出现切除不充分或不完整,鳞状细胞癌更为常见。

临床怎么用

  • 应尽快切除角质形成细胞皮肤癌,尤其对鳞状细胞癌应优先安排早期切除,尤其在资源有限时。
  • 依据BAD指南识别最高危病变,指导皮肤癌单元实践。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: British Association of Dermatologists (BAD) guidelines for managing basal (BCC) and squamous (SCC) cell skin carcinomas are distinct; however, there is a paucity of evidence relating to the histopathological behaviour of SCC and BCC over time, and the implications this has for management guidelines. OBJECTIVES: To investigate the effect of lesion duration on keratinocyte skin cancer (KSC) growth, the development of high risk factors and excision margin adequacy; further aims included investigating the impact of the presence of high or very high risk histological parameters on excision rates and clearance margins. METHODS: A cohort study was undertaken with a random sample of patients referred to our Plastic Surgery Skin Cancer Centre with BCC and SCC from January to June 2019 inclusive. Data collected included patient demographics, referral source, lesion duration (first appearance to treatment), histological data, excision margins and skin cancer risk, as defined by BAD guidelines. RESULTS: In total, 728 patients were included [397 men, 331 women; median age 77 years (interquartile range 72-85)] who underwent 872 excisions (BCC, n = 454; SCC, n = 418). Longer lesion duration was associated with increased BCC (P < 0.001 and P = 0.001, respectively) and SCC (P < 0.001 and P < 0.001, respectively) surface area and thickness on multivariable regression. The likelihood of developing very high risk histological parameters increased with SCC lesion time, including diameter > 40 mm (P < 0.001), thickness > 6 mm (P < 0.001) and total number of very high risk factors (P < 0.001). SCCs with lesion durations > 3 months had greater median surface areas (706.9 mm2 vs. 295.3 mm2; P < 0.001) and thicknesses (3.5 mm vs. 3 mm; P < 0.001) than those of ≤ 3 months' duration; the same was found for median BCC surface area (263.9 mm2 vs. 131.9 mm2; P < 0.001). A general decline in the adequate excision of BCCs and SCCs was found with an increasing number of high- or very high risk parameters. CONCLUSIONS: Longer lesion duration resulted in increased KSC thickness and surface area, and the increased presence of high risk factors as set out by the BAD. This was more common SCCs than for BCCs, and had a negative impact on surgical excision margins. Crucially, lesion duration was significantly associated with increased SCC (but not BCC) thickness at 3 months. Our results support BAD guidance on the management of KSC, identifying the highest risk lesions and informing the practice of skin cancer units. Skin cancer is one of the most common types of cancer worldwide. There are two types of skin cancer that affect skin cells called keratinocytes. The first is called squamous cell carcinoma (‘SCC’ for short). The second type is called basal cell carcinoma (‘BCC’ for short). Diagnosis of these skin cancers is based on a patient’s history, skin examination and a skin biopsy. A biopsy involves taking a small sample of the skin for testing. We wanted to find out if there is a difference in the way BCCs and SCCs grow over time. We looked at a group of 728 patients from one skin cancer service in the UK. We investigated how the time from when a patient develops a BCC or SCC to having it surgically removed affects how big the area of cancer on the skin is, how thick it is, what the risk level of the cancer is and how effective removing it is. We found similarities and differences between BCCs and SCCs. When a patient had more high or very high risk factors (according to the British Association of Dermatologists), how successfully BCCs and SCCs were removed decreased. The longer a BCC or SCC was present, the more its size increased. SCCs grew faster after 3 months and were deeper. This means they were more dangerous no matter how long they had been present. When skin cancers are surgically removed, it should be done to a minimum of 1 millimetre deep and the edges around the area removed. We found that SCCs and BCCs on the head and neck were the most likely to be inadequately or incompletely removed. This was more common for SCCs. Overall, removing keratinocyte skin cancers as soon as possible is vital. Our findings highlight how SCCs should be prioritized for earlier excision, especially when many health systems might have limited resources.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Miranda BH, Shahid S, Corriero A, et al. St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy. Br J Dermatol. 2025. PMID: 40080699. doi:10.1093/bjd/ljaf097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。